Details for New Drug Application (NDA): 064055
✉ Email this page to a colleague
NDA 064055 describes NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE, which is a drug marketed by Bausch And Lomb and is included in one NDA. Additional details are available on the NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE profile page.
The generic ingredient in NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate; neomycin sulfate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; neomycin sulfate profile page.
The generic ingredient in NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate; neomycin sulfate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; neomycin sulfate profile page.
Summary for 064055
| Tradename: | NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE |
| Applicant: | Bausch And Lomb |
| Ingredient: | dexamethasone sodium phosphate; neomycin sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML | ||||
| Approval Date: | Oct 30, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
